Breaking News on Drug Discovery

All our newsletters Free Newsletter   OK




Search
  OK
 since



News Headlines
 Emerging targets
Tools and techniques
Research management

All news articles

May 2008
April 2008
Previous months

Products & Markets

Product & Supplier News
Product Innovations
Supplier Info Centres
Market Reports
Events

Business Tools

Free Newsletters
All Newsletters
All Sites
News Syndication



Free Newsletter

 OK
All newsletters






From Europe - 3 times a week at 11.00 GMT -  Tuesday 13 May 2008

Annual round up of all drugs entering Phase I
Small molecules still leading the way into the clinic
DrugResearcher.com brings you its annual round up of all the drugs that entered clinical development in 2007, by Mike Nagle.

Many more pharma firms implicated in Iraq bribery probe
While GSK, AstraZeneca and Eli Lilly have hit the headlines in the UK Serious Fraud Office's (SFO) investigation into illegal bribes paid to Saddam Hussein's Iraqi regime, many more pharma firms are on the organisation's hit list.
New drug target leaves lung cancer cells alone, lonely and dying
It seems even tumour cells can get lonely; scientists have discovered that by cutting off a key gene, lung cancer tumour cells are left 'homeless' and they can't survive on their own.
A drug cocktail to bust brain tumours
A team of US researchers have uncovered a cocktail of three drugs that could be effective at treating every patient with a particular type of brain cancer that typically has a dismal prognosis.
IDM Pharma to cut jobs after Sanofi scraps melanoma collaboration
Sanofi-Aventis has decided to pull out of its skin cancer collaboration with IDM Pharma, leaving the Californian biopharma firm considering job cuts as a way to lower costs.

Today's headlines across the Pharmaceutical industry
Fine Foods extends within pharma
Italy's Fine Foods has purchased a domestic contract manufacturer operating in the pharmaceutical arena, extending its presence...

Quintiles in $3bn investment deal
One Equity Partners (OEP), the private equity arm of JPMorgan Chase, is in the process of selling...
Merck divests API plant; hands out large contract
Merck & Co has handed the reins of one of its US active pharmaceutical ingredient (API) manufacturing...

eClinical news in Brief
Outsourcing-Pharma tracks the latest eClinical movements, featuring Medidata, Datatrak...

Previous headlines
New China:US preclinical partnership formed
US-based MPI Research and China's Shanghai Medicilon have formed a...
Biochips help reduce the need for animal testing
US researchers have developed a new biochip technology that could...
New drug on the blocks for athletes
Scientists have discovered a potential new drug target that will...
Mapping the 'human embryome' in BioTime
BioTimes' subsidiary, Embryome Sciences, is planning to build a relational...
Pfizer buys CovX to bulk biologics pipeline
Pfizer, the world's largest pharma firm, has reached into its...
French CROs have eye on niche market
Two French contract research organisations (CROs) that specialise in ophthalmology...
NIH cash for new tools to unravel genome's secrets
The technology used to decipher an organism's gene sequence has...
Affymetrix simplifies genetic copy number analysis
Affymetrix has launched a new analysis tool for determining genetic...
Drugs moving into the clinic: 39
The last in a series of periodic roundups of drugs...
Oxford Genome Sciences advances on Amgen deal
Oxford Genome Sciences (OGeS) has taken a step closer to...

Product News on Drug Discovery
News by sponsor

All Product News
Drug discovery
Reagents (protein, genomic, PCR, cell-culture)
Chromatography
Assays and screening
Cell culture & Equipment
Compounds and consumables
Contract services (outsourcing)

Genomics / Proteomics
Informatics & IT
Lab equipment & consumables
Liquid handling and sample preparation
Microscopy / Image Analysis
Production technologies
Lab Informatics


Alerts on Product & Market Innovations !
Please indicate below your research interests and receive email alerts on relevant product and market innovations - This service is free of charge.
Drug discovery

Reagents (protein, genomic, PCR, cell-culture)

Chromatography

Assays and screening

Cell culture & Equipment

Compounds and consumables

Contract services (outsourcing)

 Genomics / Proteomics

Informatics & IT

Lab equipment & consumables

Liquid handling and sample preparation

Microscopy / Image Analysis

Production technologies

Lab Informatics
0 > Subscribe <0









Market Reports

Access the most comprehensive collection of global business intelligence for your industry. You may order directly from this site.Visit now!
Subscribe to Other Decision News Media E-newsletters - Pharmaceutical & Science
Pharmaceutical Technology
Drug Discovery
Outsourcing Pharma
Laboratory Equipment
Pharma legislation
Pharma finance
Clinical Research
Drug targeting and delivery
Innovations in pharma IT
 Cardiovascular
Central Nervous System
Alimentary & Metabolism
Respiratory
Anti-infectives & Vaccines
Musculoskeletal diseases
Oncology
Dermatologicals
Diagnostics
 Microscopy
Spectroscopy
Chromatography and Separations Sciences
Biochemistry
Cell & Molecular Biology
Decision News Media Newsletter
0 Confirm registration0 E-newsletters for food & beverage

All Decision News Media sites
Food & Beverage Development - Europe - Supplements & Nutrition - Europe - Food Processing & Packaging - Food Marketing and Retailing - Supplements & Nutrition - North America - Beverage Technology & Markets - Dairy Processing & Markets - Food Safety & Quality Control - Industrial Baking & Snacks - Confectionery & Biscuit Processing - Prepared Food and Meat Processing - Food in Central & Eastern Europe - Food and Beverage in Asia Pacific - Food & Beverage Development - North America - Pharmaceutical Technology - Drug Discovery - Laboratory Equipment - Outsourcing Pharma - Cosmetics Formulation & Packaging - North America - Cosmetics Formulation & Packaging - Europe
Partners - About us - Site map - Recommend this Site - Advertise - Contact the Editor - Terms & conditions - Privacy policy
 
© 2003/2008 – Decision News Media SAS – All Rights Reserved.

 Traffic audited by: